{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:47:49Z","timestamp":1789145269835,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H20C6a0034"],"award-info":[{"award-number":["H20C6a0034"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H20H6a0027"],"award-info":[{"award-number":["H20H6a0027"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["C210812001"],"award-info":[{"award-number":["C210812001"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007669","name":"Miyakawa Memorial Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020026","name":"Citrin Foundation","doi-asserted-by":"publisher","award":["RG21001"],"award-info":[{"award-number":["RG21001"]}],"id":[{"id":"10.13039\/501100020026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020026","name":"Citrin Foundation","doi-asserted-by":"publisher","award":["RG18003"],"award-info":[{"award-number":["RG18003"]}],"id":[{"id":"10.13039\/501100020026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jhep.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:06:07Z","timestamp":1739905567000},"page":"411-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Developing splice-switching oligonucleotides for urea cycle disorder using an integrated diagnostic and therapeutic platform"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7468-691X","authenticated-orcid":false,"given":"Jin Rong","family":"Ow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2466-240X","authenticated-orcid":false,"given":"Eri","family":"Imagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Yuan","family":"Cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1614-9374","authenticated-orcid":false,"given":"Shermin Yu Tung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3750-2472","authenticated-orcid":false,"given":"Rajasekhar Reddy","family":"Gurrampati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9920-6433","authenticated-orcid":false,"given":"Venkataramanan","family":"Ramadass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3554-5313","authenticated-orcid":false,"given":"Mun Fai","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Tabaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3461-0846","authenticated-orcid":false,"given":"Hikaru","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Tsunogai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-6530","authenticated-orcid":false,"given":"Masahide","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7595-1618","authenticated-orcid":false,"given":"Gaik Siew","family":"Ch\u2019ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2968-5707","authenticated-orcid":false,"given":"Su Seong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie Y.","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-5307","authenticated-orcid":false,"given":"Ernesto","family":"Guccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-8912","authenticated-orcid":false,"given":"Kimihiko","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keng Boon","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.02.007_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114343","article-title":"Fifteen years of urea cycle disorders brain research: looking back, looking forward","volume":"636","author":"Sen","year":"2022","journal-title":"Anal Biochem"},{"issue":"2","key":"10.1016\/j.jhep.2025.02.007_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/9667","article-title":"The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein","volume":"22","author":"Kobayashi","year":"1999","journal-title":"Nat Genet"},{"issue":"18","key":"10.1016\/j.jhep.2025.02.007_bib3","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1093\/emboj\/20.18.5060","article-title":"Citrin and aralar1 are Ca(2+)-stimulated aspartate\/glutamate transporters in mitochondria","volume":"20","author":"Palmieri","year":"2001","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.jhep.2025.02.007_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/MCB.24.2.527-536.2004","article-title":"Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia","volume":"24","author":"Sinasac","year":"2004","journal-title":"Mol Cel Biol."},{"issue":"10","key":"10.1016\/j.jhep.2025.02.007_bib5","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1074\/jbc.M610491200","article-title":"Ca2+ Activation kinetics of the two aspartate-glutamate mitochondrial carriers, aralar and citrin: role in the heart malate-aspartate NADH shuttle","volume":"282","author":"Contreras","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.jhep.2025.02.007_bib6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/jimd.12722","article-title":"Clinical landscape of citrin deficiency: a global perspective on a multifaceted condition","volume":"47","author":"Kido","year":"2024","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"10.1016\/j.jhep.2025.02.007_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s100380200046","article-title":"Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD)","volume":"47","author":"Saheki","year":"2002","journal-title":"J Hum Genet"},{"issue":"6","key":"10.1016\/j.jhep.2025.02.007_bib8","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/jimd.12673","article-title":"Improved sensitivity and specificity for citrin deficiency using selected amino acids and acylcarnitines in the newborn screening","volume":"47","author":"Kido","year":"2024","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ymgme.2019.06.004","article-title":"Current treatment for citrin deficiency during NICCD and adaptation\/compensation stages: strategy to prevent CTLN2","volume":"127","author":"Okano","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jimd.12483","article-title":"Clinical manifestation and long-term outcome of citrin deficiency: report from a nationwide study in Japan","volume":"45","author":"Kido","year":"2022","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.jhep.2025.02.007_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Nguengang","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"10197","key":"10.1016\/j.jhep.2025.02.007_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(19)31274-7","article-title":"Genomic medicine for undiagnosed diseases","volume":"394","author":"Wise","year":"2019","journal-title":"Lancet Lond Engl"},{"issue":"9","key":"10.1016\/j.jhep.2025.02.007_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","article-title":"Deep intronic mutations and human disease","volume":"136","author":"Vaz-Drago","year":"2017","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.jhep.2025.02.007_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev-med-042120-014904","article-title":"What has the undiagnosed diseases network taught us about the clinical applications of genomic testing?","volume":"73","author":"Murdock","year":"2022","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.jhep.2025.02.007_bib15","first-page":"229","article-title":"Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation","volume":"53","author":"Ogino","year":"2007","journal-title":"Kobe J Med Sci"},{"issue":"2","key":"10.1016\/j.jhep.2025.02.007_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/rth2.12031","article-title":"Identification of deep intronic individual variants in patients with hemophilia A by next-generation sequencing of the whole factor VIII gene","volume":"1","author":"Inaba","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"20","key":"10.1016\/j.jhep.2025.02.007_bib17","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.3390\/ijms20205053","article-title":"Prevalence of ABCA4 deep-intronic variants and related phenotype in an unsolved \u201cOne-Hit\u201d cohort with stargardt disease","volume":"20","author":"Nassisi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2025.02.007_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.647400","article-title":"Identification of deep-intronic splice mutations in a large cohort of patients with inherited retinal diseases","volume":"12","author":"Qian","year":"2021","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.jhep.2025.02.007_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13023-023-02742-1","article-title":"Identification of deep intronic variants of PAH in phenylketonuria using full-length gene sequencing","volume":"18","author":"Zhang","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2025.02.007_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1028545","article-title":"Rare disease emerging as a global public health priority","volume":"10","author":"Chung","year":"2022","journal-title":"Front Public Health"},{"issue":"14","key":"10.1016\/j.jhep.2025.02.007_bib21","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2025.02.007_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.omtn.2020.05.029","article-title":"Exon-skipping oligonucleotides restore functional collagen VI by correcting a common COL6A1 mutation in ullrich CMD","volume":"21","author":"Aguti","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"10.1016\/j.jhep.2025.02.007_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jcf.2021.06.003","article-title":"Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation","volume":"20","author":"Oren","year":"2021","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"9","key":"10.1016\/j.jhep.2025.02.007_bib24","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.3390\/ijms22094621","article-title":"Antisense oligonucleotide-based rescue of aberrant splicing defects caused by 15 pathogenic variants in ABCA4","volume":"22","author":"Tomkiewicz","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7367","key":"10.1016\/j.jhep.2025.02.007_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jhep.2025.02.007_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S2352-4642(21)00100-0","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study","volume":"5","author":"Finkel","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jhep.2025.02.007_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinformatics"},{"issue":"19","key":"10.1016\/j.jhep.2025.02.007_bib28","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1093\/bioinformatics\/bts480","article-title":"Snakemake--a scalable bioinformatics workflow engine","volume":"28","author":"K\u00f6ster","year":"2012","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.jhep.2025.02.007_bib29","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM [Internet]","author":"Li","year":"2013","journal-title":"arXiv"},{"issue":"10","key":"10.1016\/j.jhep.2025.02.007_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nbt.4235","article-title":"A universal SNP and small-indel variant caller using deep neural networks","volume":"36","author":"Poplin","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jhep.2025.02.007_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhep.2025.02.007_bib33","series-title":"Genomics in the cloud: using docker, GATK, and WDL in Terra","first-page":"475","author":"Van der Auwera","year":"2020"},{"issue":"16","key":"10.1016\/j.jhep.2025.02.007_bib34","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"19","key":"10.1016\/j.jhep.2025.02.007_bib35","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhep.2025.02.007_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.omtn.2017.11.004","article-title":"A sensitive in vitro approach to assess the hybridization-dependent toxic potential of high affinity gapmer oligonucleotides","volume":"10","author":"Dieckmann","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"10.1016\/j.jhep.2025.02.007_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/nat.2022.0034","article-title":"Inflammatory non-CpG antisense oligonucleotides are signaling through TLR9 in human burkitt Lymphoma B Bjab cells","volume":"32","author":"Pollak","year":"2022","journal-title":"Nucleic Acid Ther"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib38","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1124\/jpet.102.036749","article-title":"Phase I trial of ISIS 104838, a 2\u2019-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha","volume":"303","author":"Sewell","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.jhep.2025.02.007_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/nat.2022.0033","article-title":"Early-stage identification and avoidance of antisense oligonucleotides causing species-specific inflammatory responses in human volunteer peripheral blood mononuclear cells","volume":"32","author":"Burel","year":"2022","journal-title":"Nucleic Acid Ther"},{"issue":"7993","key":"10.1016\/j.jhep.2025.02.007_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genome-wide mutational constraint map quantified from variation in 76,156 human genomes [Internet]","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.02.007_bib41","article-title":"A deep intronic variant is a common cause of OTC deficiency in individuals with previously negative genetic testing","author":"Kumar","year":"2021","journal-title":"Mol Genet Metab Rep"},{"issue":"21","key":"10.1016\/j.jhep.2025.02.007_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112850","article-title":"Identification of clinical variants beyond the exome in inborn errors of metabolism","volume":"23","author":"Soriano-Sexto","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jhep.2025.02.007_bib43","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/humu.24281","article-title":"Noncoding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene","volume":"42","author":"H\u00e4berle","year":"2021","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.jhep.2025.02.007_bib44","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/s41598-018-38346-0","article-title":"Empirical evaluation of variant calling accuracy using ultra-deep whole-genome sequencing data","volume":"9","author":"Kishikawa","year":"2019","journal-title":"Sci Rep"},{"issue":"D1","key":"10.1016\/j.jhep.2025.02.007_bib45","doi-asserted-by":"crossref","first-page":"D536","DOI":"10.1093\/nar\/gkaa1034","article-title":"jMorp updates in 2020: large enhancement of multi-omics data resources on the general Japanese population","volume":"49","author":"Tadaka","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.jhep.2025.02.007_bib46","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","article-title":"Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI Splicing Subgroup","volume":"110","author":"Walker","year":"2023","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.jhep.2025.02.007_bib47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10038-008-0282-2","article-title":"Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency","volume":"53","author":"Tabata","year":"2008","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jhep.2025.02.007_bib48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fmed.2019.00265","article-title":"iPSC-derived hepatocytes as a platform for disease modeling and drug discovery","volume":"6","author":"Corbett","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001844","article-title":"Dynamics of co-transcriptional pre-mRNA folding influences the induction of dystrophin exon skipping by antisense oligonucleotides","volume":"3","author":"Wee","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jhep.2025.02.007_bib50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/hum.2011.205","article-title":"A prospective study in the rational design of efficient antisense oligonucleotides for exon skipping in the DMD gene","volume":"23","author":"Pramono","year":"2012","journal-title":"Hum Gene Ther"},{"issue":"7558","key":"10.1016\/j.jhep.2025.02.007_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature14351","article-title":"MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis","volume":"523","author":"Koh","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.02.007_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.omtn.2017.10.001","article-title":"Induced-decay of Glycine decarboxylase transcripts as an anticancer therapeutic strategy for non-small-cell lung carcinoma","volume":"9","author":"Lin","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jhep.2025.02.007_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccell.2018.06.007","article-title":"PTBP1-Mediated alternative splicing regulates the inflammatory secretome and the pro-tumorigenic effects of senescent cells","volume":"34","author":"Georgilis","year":"2018","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.jhep.2025.02.007_bib54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2019.07.003","article-title":"Therapeutic targeting of RNA splicing catalysis through inhibition of protein arginine methylation","volume":"36","author":"Fong","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jhep.2025.02.007_bib55","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1038\/s41467-020-17064-0","article-title":"PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis","volume":"11","author":"Mzoughi","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.jhep.2025.02.007_bib56","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/2159-8290.CD-19-1436","article-title":"Posttranslational regulation of the exon skipping machinery controls aberrant splicing in leukemia","volume":"10","author":"Zhou","year":"2020","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.jhep.2025.02.007_bib57","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1038\/s41467-023-44126-w","article-title":"RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing","volume":"14","author":"Maurin","year":"2023","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jhep.2025.02.007_bib58","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"19","key":"10.1016\/j.jhep.2025.02.007_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv626","article-title":"Ca2+ enrichment in culture medium potentiates effect of oligonucleotides","volume":"43","author":"Hori","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2025.02.007_bib60","article-title":"Unveiling sequence-Agnostic Mixed-chemical modification Patterns for splice-switching oligonucleotides using the NATURA platform","author":"Tommaso","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"10.1016\/j.jhep.2025.02.007_bib61","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","article-title":"Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug","volume":"28","author":"Debacker","year":"2020","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"9","key":"10.1016\/j.jhep.2025.02.007_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074544","article-title":"SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China","volume":"8","author":"Song","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2025.02.007_bib63","article-title":"Molecular diagnosis of pediatric patients with citrin deficiency in China: SLC25A13 mutation spectrum and the geographic distribution","volume":"6","author":"Lin","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jhep.2025.02.007_bib64","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/mt.2009.234","article-title":"PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer","volume":"17","author":"Saridey","year":"2009","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/nat.2016.0650","article-title":"The effects of 2\u2019-O-methoxyethyl containing antisense oligonucleotides on platelets in human clinical trials","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic Acid Ther"},{"issue":"5","key":"10.1016\/j.jhep.2025.02.007_bib66","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/oli.1.1997.7.473","article-title":"Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice","volume":"7","author":"Henry","year":"1997","journal-title":"Antisense Nucleic Acid Drug Dev"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib67","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1124\/jpet.105.084004","article-title":"Non-CpG-containing antisense 2\u2019-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88","volume":"314","author":"Senn","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib68","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2017.03.037","article-title":"Modelling urea-cycle disorder citrullinemia type 1 with disease-specific iPSCs","volume":"486","author":"Yoshitoshi-Uebayashi","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.jhep.2025.02.007_bib69","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/humu.21419","article-title":"SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3\u2019 splice site","volume":"32","author":"Doktor","year":"2011","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib70","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41591-021-01262-4","article-title":"Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson-Gilford progeria syndrome","volume":"27","author":"Puttaraju","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2025.02.007_bib71","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.omtn.2022.03.015","article-title":"Rescue of mis-splicing of a common SLC26A4 mutant associated with sensorineural hearing loss by antisense oligonucleotides","volume":"28","author":"Feng","year":"2022","journal-title":"Mol Ther - Nucleic Acids"},{"key":"10.1016\/j.jhep.2025.02.007_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/srep30377","article-title":"Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides","volume":"6","author":"Kasuya","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jhep.2025.02.007_bib73","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0192623313505781","article-title":"Species-specific inflammatory responses as a primary component for the development of glomerular lesions in mice and monkeys following chronic administration of a second-generation antisense oligonucleotide","volume":"42","author":"Frazier","year":"2014","journal-title":"Toxicol Pathol"},{"issue":"15","key":"10.1016\/j.jhep.2025.02.007_bib74","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for hereditary transthyretin amyloidosis with polyneuropathy","volume":"330","author":"Coelho","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jhep.2025.02.007_bib75","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/jcm11040982","article-title":"Volanesorsen: a new Era in the treatment of severe Hypertriglyceridemia","volume":"11","author":"Kolovou","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jhep.2025.02.007_bib76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.20140391","article-title":"Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators","volume":"212","author":"Flierl","year":"2015","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.jhep.2025.02.007_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187574","article-title":"Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia","volume":"12","author":"Sewing","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jhep.2025.02.007_bib78","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41467-021-21112-8","article-title":"Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jhep.2025.02.007_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102246","article-title":"Preclinical evaluation of stereopure antisense oligonucleotides for allele-selective lowering of mutant HTT","volume":"35","author":"Iwamoto","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"issue":"17","key":"10.1016\/j.jhep.2025.02.007_bib80","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-customized oligonucleotide therapy for a rare genetic disease","volume":"381","author":"Kim","year":"2019","journal-title":"N Engl J Med"},{"issue":"7971","key":"10.1016\/j.jhep.2025.02.007_bib81","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","article-title":"A framework for individualized splice-switching oligonucleotide therapy","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jhep.2025.02.007_bib82","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1261\/rna.079540.122","article-title":"Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations","volume":"29","author":"Aartsma-Rus","year":"2023","journal-title":"RNA"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:07:24Z","timestamp":1773349644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0168827825000832"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.02.007","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing splice-switching oligonucleotides for urea cycle disorder using an integrated diagnostic and therapeutic platform","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}